Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Dr. Alex Fässler currently holds the position of Chief Operations Officer of Bachem, a technology based company headquartered in Bubendorf, Switzerland, and a service provider to the pharma and biotech industry focused on peptide chemistry. Since 1998 he has held various management positions within the Bachem group, namely as Vice President Production, Site Manager and finally Chief Operating Officer of Bachem Americas located in Torrance, CA. As part of the expansion of the US operations, he led the design and commissioning of a new GMP production facility.
Before Dr. Fässler joined Bachem in 1998, he had assignments of increasing responsi-bility in medicinal chemistry and drug discovery at Ciba-Geigy, Basel Switzerland and Summit, NJ. As project leader with a special interest in peptidomimetics as enzyme inhibitors in Oncology and Infectious Diseases he was instrumental in the design and development of Reyataz® as a blockbuster anti-HIV medicine. Subsequently, he concentrated on novel chemistries with a global team of scientists for process research and scale-up of new drug candidates at Novartis Central Research, Macclesfield, UK.
Dr. Fässler earned his PhD in organic chemistry at the ETH Zurich, Switzerland and completed his studies in bioorganic chemistry at the University of California, Berkeley.